BioMarin (BMRN) Positive Drug Study Data; Crossroads Systems (CRDS) Patent Battle Continues

BioMarin (BMRN) Positive Drug Study Data; Crossroads Systems (CRDS) Patent Battle Continues

BioMarin Pharmaceutical Inc. (BMRN) Shares of BMRN surged more than 6% in extended-hours trading Wednesday after the company reported positive results of a Phase 2 proof-of-concept and dose finding study of BMN 111 (vosoritide) in children with achon...

Close